A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma.
Shoushtari AN, Ong LT, Schoder H, Singh-Kandah S, Abbate KT, Postow MA, Callahan MK, Wolchok J, Chapman PB, Panageas KS, Schwartz GK, Carvajal RD.
Shoushtari AN, et al. Among authors: ong lt.
Melanoma Res. 2016 Jun;26(3):272-7. doi: 10.1097/CMR.0000000000000234.
Melanoma Res. 2016.
PMID: 26795274
Free PMC article.
Clinical Trial.